Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$19.4 - $27.42 $453,242 - $640,613
-23,363 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$25.02 - $54.99 $52,366 - $115,094
2,093 Added 9.84%
23,363 $603,000
Q4 2020

Feb 11, 2021

BUY
$41.04 - $56.79 $142,162 - $196,720
3,464 Added 19.45%
21,270 $1.14 Million
Q3 2020

Nov 10, 2020

SELL
$36.42 - $57.0 $735,028 - $1.15 Million
-20,182 Reduced 53.13%
17,806 $734,000
Q2 2020

Aug 11, 2020

BUY
$39.26 - $52.73 $1.49 Million - $2 Million
37,988 New
37,988 $1.84 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.79B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.